Industry Research Reports
Home > Reports > Chemical & Material > Global Pharmaceutical Grade Niacin Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pharmaceutical Grade Niacin Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-03
Pages: 136 Pages
Report ld: 5103262
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Grade Niacin Market Size(US$)
CAGR 2025-2031
5.1%
Market Size,2031
USD 922
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 683 million
Market Forecast in 2031(Value)
US$ 922 million
CAGR
5.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Grade Niacin market is projected to grow from US$ 653 million in 2024 to US$ 922 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pharmaceutical Grade Niacin market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Lonza
- Jubilant Life Sciences
- Vertellus
- Brother Enterprises
- Zhejiang Lanbo Biotechnology
- Lasons India
- Vanetta
- DSM
- Tianjin Zhongrui Pharmaceutical
- Resonance Specialties
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Crystal
- Powder
Segment by Application
- Pharmaceutical Industry
- Daily Chemicals
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Pharmaceutical Grade Niacin study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pharmaceutical Grade Niacin: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Grade Niacin Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Crystal
1.2.3 Powder
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Grade Niacin Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Industry
1.3.3 Daily Chemicals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Grade Niacin Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Grade Niacin Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharmaceutical Grade Niacin Sales Estimates and Forecasts 2020-2031
2.4 Global Pharmaceutical Grade Niacin Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Pharmaceutical Grade Niacin Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Pharmaceutical Grade Niacin Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Pharmaceutical Grade Niacin Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Crystal Market Size by Manufacturers
4.5.2 Powder Market Size by Manufacturers
4.6 Global Pharmaceutical Grade Niacin Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Pharmaceutical Grade Niacin Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Pharmaceutical Grade Niacin Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Pharmaceutical Grade Niacin Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Pharmaceutical Grade Niacin Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Pharmaceutical Grade Niacin Sales and Revenue by Type (2020-2031)
7.4 North America Pharmaceutical Grade Niacin Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Pharmaceutical Grade Niacin Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Pharmaceutical Grade Niacin Sales and Revenue by Type (2020-2031)
8.4 Europe Pharmaceutical Grade Niacin Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Pharmaceutical Grade Niacin Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Pharmaceutical Grade Niacin Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Pharmaceutical Grade Niacin Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Pharmaceutical Grade Niacin Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Pharmaceutical Grade Niacin Sales and Revenue by Type (2020-2031)
10.4 Central and South America Pharmaceutical Grade Niacin Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Pharmaceutical Grade Niacin Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Pharmaceutical Grade Niacin Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Pharmaceutical Grade Niacin Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Pharmaceutical Grade Niacin Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Lonza
12.1.1 Lonza Corporation Information
12.1.2 Lonza Business Overview
12.1.3 Lonza Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.1.4 Lonza Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Lonza Pharmaceutical Grade Niacin Sales by Product in 2024
12.1.6 Lonza Pharmaceutical Grade Niacin Sales by Application in 2024
12.1.7 Lonza Pharmaceutical Grade Niacin Sales by Geographic Area in 2024
12.1.8 Lonza Pharmaceutical Grade Niacin SWOT Analysis
12.1.9 Lonza Recent Developments
12.2 Jubilant Life Sciences
12.2.1 Jubilant Life Sciences Corporation Information
12.2.2 Jubilant Life Sciences Business Overview
12.2.3 Jubilant Life Sciences Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.2.4 Jubilant Life Sciences Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Jubilant Life Sciences Pharmaceutical Grade Niacin Sales by Product in 2024
12.2.6 Jubilant Life Sciences Pharmaceutical Grade Niacin Sales by Application in 2024
12.2.7 Jubilant Life Sciences Pharmaceutical Grade Niacin Sales by Geographic Area in 2024
12.2.8 Jubilant Life Sciences Pharmaceutical Grade Niacin SWOT Analysis
12.2.9 Jubilant Life Sciences Recent Developments
12.3 Vertellus
12.3.1 Vertellus Corporation Information
12.3.2 Vertellus Business Overview
12.3.3 Vertellus Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.3.4 Vertellus Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Vertellus Pharmaceutical Grade Niacin Sales by Product in 2024
12.3.6 Vertellus Pharmaceutical Grade Niacin Sales by Application in 2024
12.3.7 Vertellus Pharmaceutical Grade Niacin Sales by Geographic Area in 2024
12.3.8 Vertellus Pharmaceutical Grade Niacin SWOT Analysis
12.3.9 Vertellus Recent Developments
12.4 Brother Enterprises
12.4.1 Brother Enterprises Corporation Information
12.4.2 Brother Enterprises Business Overview
12.4.3 Brother Enterprises Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.4.4 Brother Enterprises Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Brother Enterprises Pharmaceutical Grade Niacin Sales by Product in 2024
12.4.6 Brother Enterprises Pharmaceutical Grade Niacin Sales by Application in 2024
12.4.7 Brother Enterprises Pharmaceutical Grade Niacin Sales by Geographic Area in 2024
12.4.8 Brother Enterprises Pharmaceutical Grade Niacin SWOT Analysis
12.4.9 Brother Enterprises Recent Developments
12.5 Zhejiang Lanbo Biotechnology
12.5.1 Zhejiang Lanbo Biotechnology Corporation Information
12.5.2 Zhejiang Lanbo Biotechnology Business Overview
12.5.3 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.5.4 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Sales by Product in 2024
12.5.6 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Sales by Application in 2024
12.5.7 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Sales by Geographic Area in 2024
12.5.8 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin SWOT Analysis
12.5.9 Zhejiang Lanbo Biotechnology Recent Developments
12.6 Lasons India
12.6.1 Lasons India Corporation Information
12.6.2 Lasons India Business Overview
12.6.3 Lasons India Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.6.4 Lasons India Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Lasons India Recent Developments
12.7 Vanetta
12.7.1 Vanetta Corporation Information
12.7.2 Vanetta Business Overview
12.7.3 Vanetta Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.7.4 Vanetta Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Vanetta Recent Developments
12.8 DSM
12.8.1 DSM Corporation Information
12.8.2 DSM Business Overview
12.8.3 DSM Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.8.4 DSM Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 DSM Recent Developments
12.9 Tianjin Zhongrui Pharmaceutical
12.9.1 Tianjin Zhongrui Pharmaceutical Corporation Information
12.9.2 Tianjin Zhongrui Pharmaceutical Business Overview
12.9.3 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.9.4 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Tianjin Zhongrui Pharmaceutical Recent Developments
12.10 Resonance Specialties
12.10.1 Resonance Specialties Corporation Information
12.10.2 Resonance Specialties Business Overview
12.10.3 Resonance Specialties Pharmaceutical Grade Niacin Product Models, Descriptions and Specifications
12.10.4 Resonance Specialties Pharmaceutical Grade Niacin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Resonance Specialties Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Pharmaceutical Grade Niacin Industry Chain
13.2 Pharmaceutical Grade Niacin Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Pharmaceutical Grade Niacin Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Pharmaceutical Grade Niacin Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Pharmaceutical Grade Niacin Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Pharmaceutical Grade Niacin Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Grade Niacin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Grade Niacin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Grade Niacin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Grade Niacin Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Grade Niacin Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Pharmaceutical Grade Niacin Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Pharmaceutical Grade Niacin Sales by Region (2020-2025) & (Tons)
Table 8. Global Pharmaceutical Grade Niacin Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Pharmaceutical Grade Niacin Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Pharmaceutical Grade Niacin Production by Region (2020-2025) & (Tons)
Table 12. Global Pharmaceutical Grade Niacin Production by Region (2026-2031) & (Tons)
Table 13. Global Pharmaceutical Grade Niacin Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Pharmaceutical Grade Niacin Sales Share by Manufacturers (2020-2025)
Table 15. Global Pharmaceutical Grade Niacin Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Pharmaceutical Grade Niacin Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Pharmaceutical Grade Niacin by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Niacin as of 2024)
Table 19. Global Pharmaceutical Grade Niacin Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Pharmaceutical Grade Niacin Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Pharmaceutical Grade Niacin Manufacturing Base and Headquarters
Table 22. Global Pharmaceutical Grade Niacin Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Pharmaceutical Grade Niacin Sales by Type (2020-2025) & (Tons)
Table 26. Global Pharmaceutical Grade Niacin Sales by Type (2026-2031) & (Tons)
Table 27. Global Pharmaceutical Grade Niacin Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Pharmaceutical Grade Niacin Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Pharmaceutical Grade Niacin ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Pharmaceutical Grade Niacin Sales by Application (2020-2025) & (Tons)
Table 32. Global Pharmaceutical Grade Niacin Sales by Application (2026-2031) & (Tons)
Table 33. Pharmaceutical Grade Niacin High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Pharmaceutical Grade Niacin Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Pharmaceutical Grade Niacin Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Pharmaceutical Grade Niacin ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Pharmaceutical Grade Niacin Growth Accelerators and Market Barriers
Table 40. North America Pharmaceutical Grade Niacin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Pharmaceutical Grade Niacin Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Pharmaceutical Grade Niacin Growth Accelerators and Market Barriers
Table 43. Europe Pharmaceutical Grade Niacin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Pharmaceutical Grade Niacin Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Pharmaceutical Grade Niacin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Grade Niacin Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Pharmaceutical Grade Niacin Growth Accelerators and Market Barriers
Table 48. Southeast Asia Pharmaceutical Grade Niacin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Pharmaceutical Grade Niacin Investment Opportunities and Key Challenges
Table 50. Central and South America Pharmaceutical Grade Niacin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Pharmaceutical Grade Niacin Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Pharmaceutical Grade Niacin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Lonza Corporation Information
Table 54. Lonza Description and Major Businesses
Table 55. Lonza Product Models, Descriptions and Specifications
Table 56. Lonza Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Lonza Sales Value Proportion by Product in 2024
Table 58. Lonza Sales Value Proportion by Application in 2024
Table 59. Lonza Sales Value Proportion by Geographic Area in 2024
Table 60. Lonza Pharmaceutical Grade Niacin SWOT Analysis
Table 61. Lonza Recent Developments
Table 62. Jubilant Life Sciences Corporation Information
Table 63. Jubilant Life Sciences Description and Major Businesses
Table 64. Jubilant Life Sciences Product Models, Descriptions and Specifications
Table 65. Jubilant Life Sciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Jubilant Life Sciences Sales Value Proportion by Product in 2024
Table 67. Jubilant Life Sciences Sales Value Proportion by Application in 2024
Table 68. Jubilant Life Sciences Sales Value Proportion by Geographic Area in 2024
Table 69. Jubilant Life Sciences Pharmaceutical Grade Niacin SWOT Analysis
Table 70. Jubilant Life Sciences Recent Developments
Table 71. Vertellus Corporation Information
Table 72. Vertellus Description and Major Businesses
Table 73. Vertellus Product Models, Descriptions and Specifications
Table 74. Vertellus Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Vertellus Sales Value Proportion by Product in 2024
Table 76. Vertellus Sales Value Proportion by Application in 2024
Table 77. Vertellus Sales Value Proportion by Geographic Area in 2024
Table 78. Vertellus Pharmaceutical Grade Niacin SWOT Analysis
Table 79. Vertellus Recent Developments
Table 80. Brother Enterprises Corporation Information
Table 81. Brother Enterprises Description and Major Businesses
Table 82. Brother Enterprises Product Models, Descriptions and Specifications
Table 83. Brother Enterprises Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Brother Enterprises Sales Value Proportion by Product in 2024
Table 85. Brother Enterprises Sales Value Proportion by Application in 2024
Table 86. Brother Enterprises Sales Value Proportion by Geographic Area in 2024
Table 87. Brother Enterprises Pharmaceutical Grade Niacin SWOT Analysis
Table 88. Brother Enterprises Recent Developments
Table 89. Zhejiang Lanbo Biotechnology Corporation Information
Table 90. Zhejiang Lanbo Biotechnology Description and Major Businesses
Table 91. Zhejiang Lanbo Biotechnology Product Models, Descriptions and Specifications
Table 92. Zhejiang Lanbo Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Zhejiang Lanbo Biotechnology Sales Value Proportion by Product in 2024
Table 94. Zhejiang Lanbo Biotechnology Sales Value Proportion by Application in 2024
Table 95. Zhejiang Lanbo Biotechnology Sales Value Proportion by Geographic Area in 2024
Table 96. Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin SWOT Analysis
Table 97. Zhejiang Lanbo Biotechnology Recent Developments
Table 98. Lasons India Corporation Information
Table 99. Lasons India Description and Major Businesses
Table 100. Lasons India Product Models, Descriptions and Specifications
Table 101. Lasons India Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Lasons India Recent Developments
Table 103. Vanetta Corporation Information
Table 104. Vanetta Description and Major Businesses
Table 105. Vanetta Product Models, Descriptions and Specifications
Table 106. Vanetta Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Vanetta Recent Developments
Table 108. DSM Corporation Information
Table 109. DSM Description and Major Businesses
Table 110. DSM Product Models, Descriptions and Specifications
Table 111. DSM Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. DSM Recent Developments
Table 113. Tianjin Zhongrui Pharmaceutical Corporation Information
Table 114. Tianjin Zhongrui Pharmaceutical Description and Major Businesses
Table 115. Tianjin Zhongrui Pharmaceutical Product Models, Descriptions and Specifications
Table 116. Tianjin Zhongrui Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Tianjin Zhongrui Pharmaceutical Recent Developments
Table 118. Resonance Specialties Corporation Information
Table 119. Resonance Specialties Description and Major Businesses
Table 120. Resonance Specialties Product Models, Descriptions and Specifications
Table 121. Resonance Specialties Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Resonance Specialties Recent Developments
Table 123. Key Raw Materials Distribution
Table 124. Raw Materials Key Suppliers
Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 126. Milestones in Production Technology Evolution
Table 127. Distributors List
Table 128. Market Trends and Market Evolution
Table 129. Market Drivers and Opportunities
Table 130. Market Challenges, Risks, and Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Grade Niacin Product Picture
Figure 2. Global Pharmaceutical Grade Niacin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Crystal Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Pharmaceutical Grade Niacin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Pharmaceutical Industry
Figure 7. Daily Chemicals
Figure 8. Others
Figure 9. Pharmaceutical Grade Niacin Report Years Considered
Figure 10. Global Pharmaceutical Grade Niacin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 12. Global Pharmaceutical Grade Niacin Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Pharmaceutical Grade Niacin Revenue Market Share by Region (2020-2031)
Figure 14. Global Pharmaceutical Grade Niacin Sales (2020-2031) & (Tons)
Figure 15. Global Pharmaceutical Grade Niacin Sales (CAGR) by Region (2020-2031) (Tons)
Figure 16. Global Pharmaceutical Grade Niacin Sales Market Share by Region (2020-2031)
Figure 17. Global Pharmaceutical Grade Niacin Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 18. Global Pharmaceutical Grade Niacin Production Trend by Region (2020-2031) (Tons)
Figure 19. Global Pharmaceutical Grade Niacin Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Pharmaceutical Grade Niacin Production Growth Rate in North America (2020-2031) & (Tons)
Figure 22. Pharmaceutical Grade Niacin Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 23. Pharmaceutical Grade Niacin Production Growth Rate in China (2020-2031) & (Tons)
Figure 24. Pharmaceutical Grade Niacin Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 25. Top 5 and Top 10 Manufacturers Pharmaceutical Grade Niacin Sales Volume Market Share in 2024
Figure 26. Global Pharmaceutical Grade Niacin Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Crystal Revenue Market Share by Manufacturer in 2024
Figure 29. Powder Revenue Market Share by Manufacturer in 2024
Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 32. Global Pharmaceutical Grade Niacin Sales Market Share by Type (2020-2031)
Figure 33. Global Pharmaceutical Grade Niacin Revenue Market Share by Type (2020-2031)
Figure 34. Global Pharmaceutical Grade Niacin Sales Market Share by Application (2020-2031)
Figure 35. Global Pharmaceutical Grade Niacin Revenue Market Share by Application (2020-2031)
Figure 36. North America Pharmaceutical Grade Niacin Sales YoY (2020-2031) & (Tons)
Figure 37. North America Pharmaceutical Grade Niacin Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Pharmaceutical Grade Niacin Sales Revenue (US$ Million) in 2024
Figure 39. North America Pharmaceutical Grade Niacin Sales Volume (Tons) by Type (2020- 2031)
Figure 40. North America Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Pharmaceutical Grade Niacin Sales Volume (Tons) by Application (2020-2031)
Figure 42. North America Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Pharmaceutical Grade Niacin Sales YoY (2020-2031) & (Tons)
Figure 47. Europe Pharmaceutical Grade Niacin Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Pharmaceutical Grade Niacin Sales Revenue (US$ Million) in 2024
Figure 49. Europe Pharmaceutical Grade Niacin Sales Volume (Tons) by Type (2020-2031)
Figure 50. Europe Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Pharmaceutical Grade Niacin Sales Volume (Tons) by Application (2020-2031)
Figure 52. Europe Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 54. France Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Pharmaceutical Grade Niacin Sales YoY (2020-2031) & (Tons)
Figure 59. Asia-Pacific Pharmaceutical Grade Niacin Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Pharmaceutical Grade Niacin Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Pharmaceutical Grade Niacin Sales Volume (Tons) by Type (2020- 2031)
Figure 62. Asia-Pacific Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Pharmaceutical Grade Niacin Sales Volume (Tons) by Application (2020-2031)
Figure 64. Asia-Pacific Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 69. India Pharmaceutical Grade Niacin Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Pharmaceutical Grade Niacin Sales YoY (2020-2031) & (Tons)
Figure 71. Central and South America Pharmaceutical Grade Niacin Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Pharmaceutical Grade Niacin Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Pharmaceutical Grade Niacin Sales Volume (Tons) by Type (2021-2031)
Figure 74. Central and South America Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Pharmaceutical Grade Niacin Sales Volume (Tons) by Application (2020-2031)
Figure 76. Central and South America Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Pharmaceutical Grade Niacin Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Pharmaceutical Grade Niacin Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Pharmaceutical Grade Niacin Sales YoY (2020-2031) & (Tons)
Figure 80. Middle East and Africa Pharmaceutical Grade Niacin Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Pharmaceutical Grade Niacin Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Pharmaceutical Grade Niacin Sales Volume (Tons) by Type (2021-2031)
Figure 83. South America Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Pharmaceutical Grade Niacin Sales Volume (Tons) by Application (2020-2031)
Figure 85. Middle East and Africa Pharmaceutical Grade Niacin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Pharmaceutical Grade Niacin Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Pharmaceutical Grade Niacin Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Pharmaceutical Grade Niacin Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Pharmaceutical Grade Niacin Revenue (2020-2025) & (US$ Million)
Figure 90. Pharmaceutical Grade Niacin Industry Chain Mapping
Figure 91. Regional Pharmaceutical Grade Niacin Manufacturing Base Distribution (%)
Figure 92. Pharmaceutical Grade Niacin Production Process
Figure 93. Regional Pharmaceutical Grade Niacin Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Pharmaceutical Grade Niacin in 2031?
Which companies rank high in the global Pharmaceutical Grade Niacin market?
What was the global market size of Pharmaceutical Grade Niacin in 2025?
What is the annual compound growth rate of the global Pharmaceutical Grade Niacin market size from 2025 to 2031?
Related Reports
Pharmaceutical Grade Niacin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 683 million in 2025 and is projected to reach US$ 965 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 105
USD 3950.00
(Single User License)
Global Pharmaceutical Grade Niacin Market Research Report 2026
The global Pharmaceutical Grade Niacin market was valued at US$ 683 million in 2025 and is anticipated to reach US$ 965 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 134
USD 2900.00
(Single User License)
Pharmaceutical Grade Niacin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 91
USD 3950.00
(Single User License)
Global Pharmaceutical Grade Niacin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Grade Niacin market size was US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 80
USD 4250.00
(Single User License)
Global Pharmaceutical Grade Niacin Market Research Report 2025
The global market for Pharmaceutical Grade Niacin was valued at US$ 653 million in the year 2024 and is projected to reach a revised size of US$ 922 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-02-14
Pages: 94
USD 2900.00
(Single User License)
Global Pharmaceutical Grade Niacin Market Insights, Forecast to 2030
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
Global Pharmaceutical Grade Niacin Market Research Report 2024
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-02-05
Pages: 96
USD 2900.00
(Single User License)
Pharmaceutical Grade Niacin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-01-25
Pages: 122
USD 3950.00
(Single User License)
Pharmaceutical Grade Niacin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 683 million in 2025 and is projected to reach US$ 965 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-01
Pages: 105
USD 3950.00 (Single User License)Global Pharmaceutical Grade Niacin Market Research Report 2026
The global Pharmaceutical Grade Niacin market was valued at US$ 683 million in 2025 and is anticipated to reach US$ 965 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-01
Pages: 134
USD 2900.00 (Single User License)Pharmaceutical Grade Niacin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 91
USD 3950.00 (Single User License)Global Pharmaceutical Grade Niacin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Grade Niacin market size was US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 80
USD 4250.00 (Single User License)Global Pharmaceutical Grade Niacin Market Research Report 2025
The global market for Pharmaceutical Grade Niacin was valued at US$ 653 million in the year 2024 and is projected to reach a revised size of US$ 922 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-02-14
Pages: 94
USD 2900.00 (Single User License)Global Pharmaceutical Grade Niacin Market Insights, Forecast to 2030
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-04-10
Pages: 112
USD 4900.00 (Single User License)Global Pharmaceutical Grade Niacin Market Research Report 2024
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-02-05
Pages: 96
USD 2900.00 (Single User License)Pharmaceutical Grade Niacin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-01-25
Pages: 122
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now